Development of tripeptidyl farnesyltransferase inhibitors
Cited 8 time in 
Metadata Downloads
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hee Yoon Lee | - |
| dc.contributor.author | Jeong Hun Sohn | - |
| dc.contributor.author | Byoung-Mog Kwon | - |
| dc.date.accessioned | 2017-04-19T08:58:59Z | - |
| dc.date.available | 2017-04-19T08:58:59Z | - |
| dc.date.issued | 2002 | - |
| dc.identifier.issn | 0960-894X | - |
| dc.identifier.uri | 10.1016/S0960-894X(02)00227-5 | ko |
| dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/5814 | - |
| dc.description.abstract | The first example of tripeptide inhibitors of farnesyltransferase with sub-micromolar inhibition activity was developed based on the fact that CVFM is not a substrate for farnesyltransferase. | - |
| dc.publisher | Elsevier | - |
| dc.title | Development of tripeptidyl farnesyltransferase inhibitors | - |
| dc.title.alternative | Development of tripeptidyl farnesyltransferase inhibitors | - |
| dc.type | Article | - |
| dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
| dc.citation.number | 12 | - |
| dc.citation.endPage | 1602 | - |
| dc.citation.startPage | 1599 | - |
| dc.citation.volume | 12 | - |
| dc.contributor.affiliatedAuthor | Byoung-Mog Kwon | - |
| dc.contributor.alternativeName | 이희윤 | - |
| dc.contributor.alternativeName | 손정훈 | - |
| dc.contributor.alternativeName | 권병목 | - |
| dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, vol. 12, no. 12, pp. 1599-1602 | - |
| dc.identifier.doi | 10.1016/S0960-894X(02)00227-5 | - |
| dc.description.journalClass | Y | - |
- Appears in Collections:
- 1. Journal Articles > Journal Articles
- Files in This Item:
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.